5news.U.S. news, all in one place

BREAKING

› Russia is 'going backwards' in equipment and deploying post WWII-era tanks, according to Western officials › Podcast: One country musician is calling for other artists to oppose assault rifles › Bidets save you money and reduce waste — we tested the best options out there › 50+ products to make your life easier and our planet cleaner › Mother's Day is around the corner. Here are 50+ thoughtful gifts she'll love › A head-to-toe guide of how men should dress this spring, and where they should shop › 42 of the most useful travel products you can buy on Amazon › The 7 best high-yield savings accounts of April 2023 › Taxes are due tomorrow. Here's how to file for an extension › Composting is an easy way to reduce food waste. Here's how to do it › Russia is 'going backwards' in equipment and deploying post WWII-era tanks, according to Western officials › Podcast: One country musician is calling for other artists to oppose assault rifles › Bidets save you money and reduce waste — we tested the best options out there › 50+ products to make your life easier and our planet cleaner › Mother's Day is around the corner. Here are 50+ thoughtful gifts she'll love › A head-to-toe guide of how men should dress this spring, and where they should shop › 42 of the most useful travel products you can buy on Amazon › The 7 best high-yield savings accounts of April 2023 › Taxes are due tomorrow. Here's how to file for an extension › Composting is an easy way to reduce food waste. Here's how to do it

Business

Moderna’s stock doubles on promising cancer-vaccine results

MarketWatch · August 19, 2026 at 8:40 AM

Moderna’s stock doubles on promising cancer-vaccine results

The vaccine candidate pairs an mRNA therapy with the cancer drug Keytruda.

Read the full article on MarketWatch ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.marketwatch.com — the content belongs to MarketWatch.

This story in other outlets

Moderna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 90%

CNBC · 24 min ago

More from MarketWatch

‘We are committed Christians’: Our son and daughter-in-law cut us out of their lives after a political argument. Should we change our $3 million will?

MarketWatch · 7 min ago

The bond selloff is rattling investors, but here’s why they shouldn’t expect a deeper stock downturn

MarketWatch · 14 min ago

I’m leaving my grandkids money — but they must pass financial-literacy classes to get it. Is that fair?

MarketWatch · 15 min ago

Marvell’s stock surges on news of Google chip deal — and Broadcom’s falls

MarketWatch · 17 min ago

More in Business

‘We are committed Christians’: Our son and daughter-in-law cut us out of their lives after a political argument. Should we change our $3 million will?

MarketWatch · 7 min ago

Treasury doubles debt buybacks as Bessent moves to steady bond market

CNBC · 7 min ago

I toured a Concorde, the discontinued supersonic commercial jet flown by celebrities and royals. Take a look inside.

Business Insider · 7 min ago

These are 35 of the most beautiful beaches across the US

Business Insider · 8 min ago

Target says its turnaround is picking up steam, with help from a big tariff refund

CNBC · 13 min ago

The bond selloff is rattling investors, but here’s why they shouldn’t expect a deeper stock downturn

MarketWatch · 14 min ago